港股異動丨康龍化成(03759.HK)漲近5%再創新高 中期淨利潤大增196.9%
格隆匯8月27日丨康龍化成(03759.HK)高開上漲,現報94.2港元創新高,漲4.67%,暫成交700萬港元,最新總市值。康龍化成8月26日發佈公告,上半年公司實現營業收入21.93億元,同比增長34%;歸屬於上市公司股東的淨利潤4.79億元,同比增長196.9%。報告期內,公司在2020年上半年引入逾190家新客户,公司龐大、多元化和忠實的重複客户為公司貢獻了90%以上的收入,其中包括全球前二十大醫藥公司。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.